| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/26/2004 | US20040166120 Polypeptides; free of adjuvants; antigen immunology response |
| 08/26/2004 | US20040166119 Prevention and treatment of amyloidogenic disease |
| 08/26/2004 | US20040166118 Immunocastration of pigs |
| 08/26/2004 | US20040166117 Overexpression of protease hepsin; induce immunology response; inoculation with hepsin peptide; monitoring immunotherapy |
| 08/26/2004 | US20040166116 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 08/26/2004 | US20040166111 Administering tumor necrosis factor inhibitor; antiarthritic agents; bone disorders; antiinflammatory agents |
| 08/26/2004 | US20040166109 Modulator polypeptide for regulation of intracellular endocytosis of amyloid precursor proteins; diagnosis and treatment of neurodegenerative disorders |
| 08/26/2004 | US20040166105 Compositions and methods relating to breast specific genes and proteins |
| 08/26/2004 | US20040166092 Use of viral vectors and charged molecules for gene therapy |
| 08/26/2004 | DE10306789A1 Composition for administration to living organisms, useful for labeling treated organisms, comprises active agent and a protein complex comprising viral capsomers |
| 08/26/2004 | DE10306464A1 Vaccination process, useful for preventing many diseases and for accelerating wound healing, where active components are applied to the skin beneath finger or toe nails |
| 08/26/2004 | CA2520591A1 Improved heat shock protein-based vaccines and immunotherapies |
| 08/26/2004 | CA2515699A1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 08/26/2004 | CA2515444A1 Immunoglobulin formulation and method of preparation thereof |
| 08/26/2004 | CA2515397A1 New pharmaceutical compositions based on anticholinergics and anti-tnf antibodies |
| 08/26/2004 | CA2515368A1 Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 08/26/2004 | CA2515083A1 Topical delivery of cosmetic agents |
| 08/26/2004 | CA2514997A1 Use of il-6 antagonists in combination with steroids to enhance apoptosis |
| 08/26/2004 | CA2514969A1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 08/26/2004 | CA2514955A1 Compositions for modulating immune cell activity and methods for detection thereof |
| 08/26/2004 | CA2514794A1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 08/26/2004 | CA2514231A1 Uses of anti-insulin-like growth factor i receptor antibodies |
| 08/26/2004 | CA2513668A1 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 08/26/2004 | CA2513061A1 Hsp60 from arthrobacter |
| 08/26/2004 | CA2512934A1 Short immunomodulatory oligonucleotides |
| 08/26/2004 | CA2511623A1 Remedy for cancer |
| 08/26/2004 | CA2456873A1 West nile virus proteins and genes coding the foregoing and their use in vaccinal, therapeutic and diagnostic applications |
| 08/25/2004 | EP1449922A2 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
| 08/25/2004 | EP1449921A2 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 08/25/2004 | EP1449850A1 Human cdr-grafted antibodies and antibody fragments thereof |
| 08/25/2004 | EP1449538A1 Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation |
| 08/25/2004 | EP1449535A1 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 08/25/2004 | EP1448984A2 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 08/25/2004 | EP1448787A2 Human monoclonal antibodies to dendritic cells |
| 08/25/2004 | EP1448780A2 Direct targeting binding proteins |
| 08/25/2004 | EP1448771A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof |
| 08/25/2004 | EP1448770A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 08/25/2004 | EP1448603A2 Fusion proteins containing tlp peptides |
| 08/25/2004 | EP1448602A2 Modified anti-tnf alpha antibody |
| 08/25/2004 | EP1448599A2 Inhibitors of the notch signalling pathway for use in the treatment of cancer |
| 08/25/2004 | EP1448598A2 Novel immunogenic mimetics of multimer proteins |
| 08/25/2004 | EP1448589A2 Sperm-specific cation channel, catsper2, and uses therefor |
| 08/25/2004 | EP1448588A2 Psma antibodies and protein multimers |
| 08/25/2004 | EP1448230A2 Adjuvanted antigenic meningococcal compositions |
| 08/25/2004 | EP1448229A2 Pharmaceutical composition for inducing an immune response in a human or animal |
| 08/25/2004 | EP1448227A2 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 08/25/2004 | EP1448223A2 Thymosin augmentation of genetic immunization |
| 08/25/2004 | EP1448216A2 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 08/25/2004 | EP1448212A1 Mint extract pharmaceutical compositions |
| 08/25/2004 | EP1448152A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047 |
| 08/25/2004 | EP1190257B1 Early detection of flaviviruses using the ns1 glycoprotein |
| 08/25/2004 | EP1140162B1 Vaccination method for efficient induction of cytotoxic t lymphocyte response |
| 08/25/2004 | EP1078066B1 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis |
| 08/25/2004 | EP1077719B1 Vaccine delivery system based on gonococcal blebosomes |
| 08/25/2004 | EP0922092B1 Method of attenuating viruses |
| 08/25/2004 | EP0918541B1 Immunstimulating lipid formulation |
| 08/25/2004 | EP0881906B1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/25/2004 | EP0839054B1 Tissue or cell-specific herpes simplex virus replication |
| 08/25/2004 | EP0833903B1 Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection |
| 08/25/2004 | EP0826051B1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
| 08/25/2004 | EP0724632B1 Stem cell proliferation factor |
| 08/25/2004 | EP0700441B1 Multiple sclerosis virus |
| 08/25/2004 | CN1524123A A soluble complex comprising a retroviral surface glycoprotein |
| 08/25/2004 | CN1524091A Anti pilyrosporum ovale LGY and its uses |
| 08/25/2004 | CN1524088A A virus causing respiratory tract illness in susceptible mammals |
| 08/25/2004 | CN1524002A Treatment or prophylaxis of insulin-producing cell graft rejection |
| 08/25/2004 | CN1523999A DNA expression vectors and methods of use |
| 08/25/2004 | CN1523988A Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 08/25/2004 | CN1523103A Pseudorabies TK*/gE*/gI* gene dificiency mark live vaccine and preparation method thereof |
| 08/25/2004 | CN1523039A Monoclonal antibody GDK-1 of anti-cell membrane glucoprotein KD-43 and its iodide DGDK-1 and application |
| 08/25/2004 | CN1522762A Adjuvant free GRH antibody polypeptide vaccine and its preparation method |
| 08/25/2004 | CN1522761A Composite hepatitis B vaccine for treatment and its preparation method |
| 08/25/2004 | CN1522760A Bivalent gene engineering vaccine of fowl infectious bursal disease and pasteurellosis |
| 08/25/2004 | CN1163754C Method for diagnosing a patient for chlamydia |
| 08/25/2004 | CN1163609C Expression vector pBVIL1 and its construction method and use |
| 08/25/2004 | CN1163602C Fusion protein of tubercle bacillus antigen, and its use |
| 08/25/2004 | CN1163599C Anti-GPIIB/IIIA recombination antibody |
| 08/25/2004 | CN1163594C Stimulation of hematopoietic cell in vitro |
| 08/25/2004 | CN1163512C Humanized neutralizing genetic engineering Fab antibody of anti hepatitis A virus |
| 08/25/2004 | CN1163511C Yolk anti-interleukin -8 antibody, preparation method and its application |
| 08/25/2004 | CN1163509C RET ligand (RetL) for stimulating neural and renal growth |
| 08/25/2004 | CN1163503C Virus clearance process |
| 08/25/2004 | CN1163273C Antimatrix metalloprotease monovalent antibody Fab' medicine conjugate and its tumor-resisting action |
| 08/25/2004 | CN1163272C Application of TNF antagonists as medicaments for treating septic diseases |
| 08/25/2004 | CN1163271C Synthetic peptide vaccine of influenzand its preparing process |
| 08/25/2004 | CN1163270C Modified meningococcal polysacharide conjugate vaccines |
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780890 Contacting s-adenosylhomocysteine (sah with a luxs protein whereby s- adenosylhomocysteine undergoes conversion to autoinducer-2 |
| 08/24/2004 | US6780630 Comprises live and inactivated vaccines; immunogens; for human and animal infants |
| 08/24/2004 | US6780626 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/24/2004 | US6780624 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 08/24/2004 | US6780611 G protein coupled receptors; drug screening |
| 08/24/2004 | US6780598 Method of identifying and locating immunobiologically-active linear peptides |
| 08/24/2004 | US6780586 Methods of diagnosing breast cancer |
| 08/24/2004 | US6780421 Vaccine composition comprising at least one antigen and adjuvanting amount of 3-beta-(n-(n',n'-dimethylaminoethane)carbamoyl) cholesterol |
| 08/24/2004 | US6780420 Carrier protein having an adjuvant effect, immunogenic complex containing it, process for their preparation, nucleotide sequence and vaccine |
| 08/24/2004 | US6780419 Isolated polypeptide comprising specified amino acid sequence or immunogenic fragment of at least 15 contiguous amino acids, which when administered to subject induces antibody or t-cell mediated immune response that recognizes polypeptide |
| 08/24/2004 | US6780417 Transmission blocking immunogen from malaria |
| 08/24/2004 | US6780416 Bee venom polypeptides and methods of use thereof |
| 08/24/2004 | US6780415 Animal model for infection by an apicomplexan parasite |